TY - JOUR
T1 - Implications of an off-hours setting in patients undergoing transcatheter edge-to-edge repair for mitral regurgitation
AU - Shechter, Alon
AU - Gupta, Aakriti
AU - Kaewkes, Danon
AU - Taheri, Homa
AU - Nagasaka, Takashi
AU - Patel, Vivek
AU - Suruga, Kazuki
AU - Hong, Gloria J.
AU - Koseki, Keita
AU - Koren, Ofir
AU - Makar, Moody
AU - Skaf, Sabah
AU - Patel, Dhairya
AU - Chakravarty, Tarun
AU - Siegel, Robert J.
AU - Makkar, Raj R.
N1 - Publisher Copyright:
© 2024 Elsevier Inc.
PY - 2025/4
Y1 - 2025/4
N2 - Background: Little is known about transcatheter edge-to-edge repair (TEER) for mitral regurgitation (MR) that is performed outside of usual working hours. We aimed to explore the prevalence, correlates, and outcomes of mitral TEER initiated off-hours, ie, before 7:30 am, after 5:30 pm, or on weekends/holidays. Methods: A single-center registry of isolated, first-time interventions was retrospectively analyzed in its entirety and after propensity-score matching. Outcomes included all-cause mortality, heart failure (HF) hospitalizations, and the persistence of MR and functional incapacitation along the first postprocedural year. Results: A total of 1,177 procedures were studied. Of them, 117 (9.9%) took place off-hours. These were more often urgent interventions (30.8% vs. 14.3%, P < .001) performed in the midst of acute HF / hemodynamic compromise and on individuals with greater comorbidity, more advanced HF, and higher interventional risk. Overall procedural features were unaffected by interventional timing, and a high (>97%) technical success rate was achieved unanimously. MR severity and functional class similarly improved from baseline in the 2 study groups. Deaths and the composite of deaths or HF hospitalizations occurred earlier and more frequently following off-hours procedures (18.8% vs. 11.5%, P = .022 and 33.3% vs. 24.6%, P = .040, respectively). None of the explored endpoints’ risks were independently associated with procedural timing. Within a 234-patient, 1-to-1 matched sub-cohort, no inter-group differences were observed in pre-, intra-, and postprocedural findings and outcomes. Conclusions: A noninfrequent procedure, off-hours mitral TEER is performed in high-risk cases but, in the hands of experienced interventionalists, should prove safe, feasible, and efficacious.
AB - Background: Little is known about transcatheter edge-to-edge repair (TEER) for mitral regurgitation (MR) that is performed outside of usual working hours. We aimed to explore the prevalence, correlates, and outcomes of mitral TEER initiated off-hours, ie, before 7:30 am, after 5:30 pm, or on weekends/holidays. Methods: A single-center registry of isolated, first-time interventions was retrospectively analyzed in its entirety and after propensity-score matching. Outcomes included all-cause mortality, heart failure (HF) hospitalizations, and the persistence of MR and functional incapacitation along the first postprocedural year. Results: A total of 1,177 procedures were studied. Of them, 117 (9.9%) took place off-hours. These were more often urgent interventions (30.8% vs. 14.3%, P < .001) performed in the midst of acute HF / hemodynamic compromise and on individuals with greater comorbidity, more advanced HF, and higher interventional risk. Overall procedural features were unaffected by interventional timing, and a high (>97%) technical success rate was achieved unanimously. MR severity and functional class similarly improved from baseline in the 2 study groups. Deaths and the composite of deaths or HF hospitalizations occurred earlier and more frequently following off-hours procedures (18.8% vs. 11.5%, P = .022 and 33.3% vs. 24.6%, P = .040, respectively). None of the explored endpoints’ risks were independently associated with procedural timing. Within a 234-patient, 1-to-1 matched sub-cohort, no inter-group differences were observed in pre-, intra-, and postprocedural findings and outcomes. Conclusions: A noninfrequent procedure, off-hours mitral TEER is performed in high-risk cases but, in the hands of experienced interventionalists, should prove safe, feasible, and efficacious.
UR - http://www.scopus.com/inward/record.url?scp=85215861061&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2024.12.012
DO - 10.1016/j.ahj.2024.12.012
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39755327
AN - SCOPUS:85215861061
SN - 0002-8703
VL - 282
SP - 70
EP - 80
JO - American Heart Journal
JF - American Heart Journal
ER -